Skip to main content
Livermore
Livermore
ZHEN

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Immunovant, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of IMVT: Q4 2023 compared with Q1 2024
MeasureQ4 2023Of which not filed for Q1 2024Q1 2024Change
Holders2281209−18
Shares68.4M53.0K70.4M+2.04M (+3.0%)
Value$2.88B$2.23M$2.27B−$606.7M (−21.1%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Immunovant, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to IMVT in Q1 2024
InstitutionSharesValue% of portfolio
Viking Global Investors LPSuperinvestorViking Global Investors1,809,172$58.5M0.22%
Paradigm Biocapital Advisors LP799,054$25.8M0.91%
Prosight Management, LP195,000$6.30M1.75%
Ghost Tree Capital, LLC125,000$4.04M1.30%
Caption Management, LLC113,477$3.67M0.40%
Castleark Management LLC80,440$2.60M0.11%
Trexquant Investment LP58,218$1.88M0.04%
Marshall Wace, LLP53,533$1.73M0.00%
Aquatic Capital Management LLC52,000$1.68M0.05%
Squarepoint Ops LLC46,673$1.51M0.01%
Pearl River Capital, LLC26,053$841.8K0.13%
Nomura Holdings Inc25,708$830.6K0.01%
PEAK6 Investments LLC22,944$741.3K0.04%
Dynamic Technology Lab Private Ltd17,670$571.0K0.06%
Cantor Fitzgerald, L. P.17,335$560.1K0.13%
Verition Fund Management LLC9,360$302.4K0.00%
DnB Asset Management AS9,332$301.5K0.00%
XTX Topco Ltd9,237$298.4K0.04%
Corton Capital Inc.9,027$291.7K0.11%
Twinbeech Capital LP7,401$239.1K0.00%
HSBC Holdings PLC7,298$235.8K0.00%
Cutler Group LP2,000$64.0K0.03%
Pacer Advisors, Inc.1,343$43.4K0.00%
Old Point Trust & Financial Services N A250$8.08K0.00%
Ci Investments Inc.110$4.00K0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC11$3550.00%
Rothschild Investment LLC5$1620.00%
EverSource Wealth Advisors, LLC3$820.00%

Sold out (46)

Institutions that held Immunovant, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of IMVT in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Cormorant Asset Management, LP1,165,000$49.1M
Farallon Capital Management, L.L.C.341,000$14.4M
Jennison Associates LLC313,205$13.2M
BVF Inc300,000$12.6M
Sofinnova Investments, Inc.222,553$9.38M
Superstring Capital Management LP203,592$8.58M
Soros Fund Management LLCSuperinvestorSoros Fund Management140,000$5.90M
HighVista Strategies LLC121,287$5.11M
HRT Financial LP92,731$3.91M
Lighthouse Investment Partners, LLC86,180$3.63M
Altium Capital Management LP80,000$3.37M
Weiss Multi-Strategy Advisers LLC75,631$3.19M
Cowen and Company, LLC69,410$2.92M
Alyeska Investment Group, L.P.61,820$2.60M
Neuberger Berman Group LLC43,720$1.84M
Healthcare of Ontario Pension Plan Trust Fund33,000$1.39M
Velan Capital Investment Management LP27,500$1.16M
New York Life Investment Management LLC22,438$945.3K
Jefferies Financial Group Inc.21,574$908.9K
Walleye Trading LLC20,390$859.0K
Silverarc Capital Management, LLC20,000$842.6K
Two Sigma Advisers, LP19,400$817.3K
Natixis16,900$712.0K
Fox Run Management, L.L.C.14,534$612.3K
GTS Securities LLC14,286$601.9K
Jupiter Asset Management Ltd11,165$470.4K
Captrust Financial Advisors10,792$454.7K
Maven Securities LTD10,000$421.3K
Balyasny Asset Management LLC9,783$412.2K
Y-Intercept (Hong Kong) Ltd9,241$389.3K
Gsa Capital Partners LLP8,760$369.0K
Engineers Gate Manager LP8,451$356.0K
Point72 Middle East FZE8,272$348.5K
JFG Wealth Management, LLC7,000$294.9K
Bailard, Inc.6,300$265.4K
Pictet & Cie (Europe) SA5,512$232.2K
Atom Investors LP5,431$228.8K
Torno Capital, LLC5,000$210.7K
Federated Hermes, Inc.2,979$125.5K
Point72 Asia (Singapore) Pte. Ltd.1,104$46.5K
Headlands Technologies LLC636$26.8K
Itau Unibanco Holding S.A.65$2.74K
Fortitude Family Office, LLC21$885
Bell Investment Advisors, Inc15$632
Tfo-TDC, LLC9$379
Gradient Investments LLC2$84

Not filed for Q1 2024 yet (1)

Institutions that held Immunovant, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q4 2023 that haven't filed for Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Putnam Investments LLC52,984$2.23M